Cameron Day, Ph.D

Cameron Day, Ph.D has a diverse work experience in the field of biosciences. In 2008, they started their career as a Student Researcher at UT Southwestern, where they conducted a genome-wide RNAi screen to identify genetic modulators of ALS. Cameron'sresearch revealed a previously unknown interaction between SOD1 and TDP43 proteins, both implicated in ALS pathogenesis. Cameron also demonstrated the modulation of SOD1 expression using the TrkB neurotrophin receptor in a cell model of ALS.

Following this, from 2014 to 2017, Day worked as a Postdoctoral Associate at the University of Utah Health Sciences. During this time, they conducted two parallel studies focusing on investigating the protein machinery regulating AMPA-receptor endocytosis in neurons using a proteomics-based approach. Additionally, their studies involved the characterization of a novel structural form of the protein Arc, which is essential for AMPA-receptor trafficking and memory encoding.

Currently, Cameron Day holds the role of Scientist at Echelon Biosciences, a position they have held since 2018.

Cameron Day, Ph.D, completed a Bachelor of Science degree in Neuroscience, specializing in Neurobiology and Neurosciences, from Texas Christian University from 2005 to 2008. Following this, they pursued further education at UT Southwestern Medical Center from 2008 to 2014, where they obtained a Doctor of Philosophy (PhD) in Molecular Biology.